The form is Injectable vial (5mL, 1.2mg-2mg-2mg-2mg/mL, AOD-9604 6mg + MOTs-C 10mg + Tesamorelin 10mg + Ipamorelin 10mg total)
The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)
\Lean Mass Preservation: Observed fat loss without a decrease in muscle mass (Animal Study)
For general prevention in individuals at risk of deficiencysuch as vegans and vegetarianstypical UK recommendations include cyanocobalamin supplements providing 10-100 micrograms daily or approximately 2000 micrograms weekly
AHK-Cu has been examined in a much smaller body of work concentrated on hair follicle and dermal cell systems
PubMed laboratory research record [PMID: 37867024] PubMed record related to this compound for laboratory literature review